Future of Drug Discovery

Rahmad Akbar - Frontiers of AI Antibody Design (FODD #17)

Listen Later

This episode is a discussion between ⁠Rahmad Akbar, Senior Data Scientist in Antibody Design at Novo Nordisk and Murat Tunaboylu⁠, Co-Founder and CEO of Antiverse⁠.

You will learn:

  • The impact antibody design has on the world.
  • How AI is helping to push antibody design forward, bringing new therapies to patients.
  • What will antibody design look like in the future?


    • Rahmad's LinkedIn page.

    Rahmad's Personal Website.

    Antibody Origami: Here.

    Rahmad's Previous and Existing Team: Victor Greiff (GreiffLab). Paolo Marcatili, Ludovica Beltrame, Rasmus Høiberg-Nielsen (Antibody Design at Novo Nordisk).


    "And a big shout out to budding antibody designers (scientists) everywhere especially from my home country Indonesia!' - Rahmad.

    Be sure to like, rate and review the podcast if you enjoyed this episode!
    Visit our website: https://www.antiverse.io/
    Follow us:
    LinkedIn: ⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/company/antiverse/⁠⁠⁠⁠⁠⁠⁠
    X: ⁠⁠⁠⁠⁠⁠⁠https://twitter.com/AntiverseHQ⁠⁠

    ...more
    View all episodesView all episodes
    Download on the App Store
    Future of Drug DiscoveryBy Murat Tunaboylu